Global Polio Vaccine Market Insights and Forecast to 2028

Q: Who are the key players in the polio vaccine market?

Some of the key players are World Health Organization, Sanofi, GSK, Bibcol, Serum Institute, Tiantan biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals, Company, Japan, Russia, Others.

Code: QYRE-Auto-34U455

Report

January 2022

Pages:91

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

Company

Japan

Russia

World Health Organization

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.

Market Analysis and Insights: Global Polio Vaccine Market

Due to the COVID-19 pandemic, the global Polio Vaccine market size is estimated to be worth US$ 742.2 million in 2022 and is forecast to a readjusted size of US$ 949.9 million by 2028 with a CAGR of 4.2% during the review period.

Fully considering the economic change by this health crisis, Inactivated Polio Vaccine (IPV) accounting for % of the Polio Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Public segment is altered to an % CAGR throughout this forecast period.

Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.

Global Polio Vaccine Scope and Segment

Polio Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Polio Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Inactivated Polio Vaccine (IPV)

Oral Polio Vaccine (OPV)

Segment by Application

Public

Private

BY COMPANY

Sanofi

GSK

Bibcol

Serum Institute

Tiantan Biological

IMBCA

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

BY REGION

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

Company

Japan

Russia

World Health Organization

1 Study Coverage

1.1 Polio Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Inactivated Polio Vaccine (IPV)

1.2.3 Oral Polio Vaccine (OPV)

1.3 Market by Application

1.3.1 Global Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Public

1.3.3 Private

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Polio Vaccine Sales Estimates and Forecasts 2017-2028

2.2 Global Polio Vaccine Revenue Estimates and Forecasts 2017-2028

2.3 Global Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Polio Vaccine Sales by Region

2.4.1 Global Polio Vaccine Sales by Region (2017-2022)

2.4.2 Global Sales Polio Vaccine by Region (2023-2028)

2.5 Global Polio Vaccine Revenue by Region

2.5.1 Global Polio Vaccine Revenue by Region (2017-2022)

2.5.2 Global Polio Vaccine Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Polio Vaccine Sales by Manufacturers

3.1.1 Global Top Polio Vaccine Manufacturers by Sales (2017-2022)

3.1.2 Global Polio Vaccine Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Polio Vaccine in 2021

3.2 Global Polio Vaccine Revenue by Manufacturers

3.2.1 Global Polio Vaccine Revenue by Manufacturers (2017-2022)

3.2.2 Global Polio Vaccine Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Polio Vaccine Revenue in 2021

3.3 Global Polio Vaccine Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Polio Vaccine Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Polio Vaccine Sales by Type

4.1.1 Global Polio Vaccine Historical Sales by Type (2017-2022)

4.1.2 Global Polio Vaccine Forecasted Sales by Type (2023-2028)

4.1.3 Global Polio Vaccine Sales Market Share by Type (2017-2028)

4.2 Global Polio Vaccine Revenue by Type

4.2.1 Global Polio Vaccine Historical Revenue by Type (2017-2022)

4.2.2 Global Polio Vaccine Forecasted Revenue by Type (2023-2028)

4.2.3 Global Polio Vaccine Revenue Market Share by Type (2017-2028)

4.3 Global Polio Vaccine Price by Type

4.3.1 Global Polio Vaccine Price by Type (2017-2022)

4.3.2 Global Polio Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Polio Vaccine Sales by Application

5.1.1 Global Polio Vaccine Historical Sales by Application (2017-2022)

5.1.2 Global Polio Vaccine Forecasted Sales by Application (2023-2028)

5.1.3 Global Polio Vaccine Sales Market Share by Application (2017-2028)

5.2 Global Polio Vaccine Revenue by Application

5.2.1 Global Polio Vaccine Historical Revenue by Application (2017-2022)

5.2.2 Global Polio Vaccine Forecasted Revenue by Application (2023-2028)

5.2.3 Global Polio Vaccine Revenue Market Share by Application (2017-2028)

5.3 Global Polio Vaccine Price by Application

5.3.1 Global Polio Vaccine Price by Application (2017-2022)

5.3.2 Global Polio Vaccine Price Forecast by Application (2023-2028)

6 North America

6.1 North America Polio Vaccine Market Size by Type

6.1.1 North America Polio Vaccine Sales by Type (2017-2028)

6.1.2 North America Polio Vaccine Revenue by Type (2017-2028)

6.2 North America Polio Vaccine Market Size by Application

6.2.1 North America Polio Vaccine Sales by Application (2017-2028)

6.2.2 North America Polio Vaccine Revenue by Application (2017-2028)

6.3 North America Polio Vaccine Market Size by Country

6.3.1 North America Polio Vaccine Sales by Country (2017-2028)

6.3.2 North America Polio Vaccine Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Polio Vaccine Market Size by Type

7.1.1 Europe Polio Vaccine Sales by Type (2017-2028)

7.1.2 Europe Polio Vaccine Revenue by Type (2017-2028)

7.2 Europe Polio Vaccine Market Size by Application

7.2.1 Europe Polio Vaccine Sales by Application (2017-2028)

7.2.2 Europe Polio Vaccine Revenue by Application (2017-2028)

7.3 Europe Polio Vaccine Market Size by Country

7.3.1 Europe Polio Vaccine Sales by Country (2017-2028)

7.3.2 Europe Polio Vaccine Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Polio Vaccine Market Size by Type

8.1.1 Asia Pacific Polio Vaccine Sales by Type (2017-2028)

8.1.2 Asia Pacific Polio Vaccine Revenue by Type (2017-2028)

8.2 Asia Pacific Polio Vaccine Market Size by Application

8.2.1 Asia Pacific Polio Vaccine Sales by Application (2017-2028)

8.2.2 Asia Pacific Polio Vaccine Revenue by Application (2017-2028)

8.3 Asia Pacific Polio Vaccine Market Size by Region

8.3.1 Asia Pacific Polio Vaccine Sales by Region (2017-2028)

8.3.2 Asia Pacific Polio Vaccine Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Polio Vaccine Market Size by Type

9.1.1 Latin America Polio Vaccine Sales by Type (2017-2028)

9.1.2 Latin America Polio Vaccine Revenue by Type (2017-2028)

9.2 Latin America Polio Vaccine Market Size by Application

9.2.1 Latin America Polio Vaccine Sales by Application (2017-2028)

9.2.2 Latin America Polio Vaccine Revenue by Application (2017-2028)

9.3 Latin America Polio Vaccine Market Size by Country

9.3.1 Latin America Polio Vaccine Sales by Country (2017-2028)

9.3.2 Latin America Polio Vaccine Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Polio Vaccine Market Size by Type

10.1.1 Middle East and Africa Polio Vaccine Sales by Type (2017-2028)

10.1.2 Middle East and Africa Polio Vaccine Revenue by Type (2017-2028)

10.2 Middle East and Africa Polio Vaccine Market Size by Application

10.2.1 Middle East and Africa Polio Vaccine Sales by Application (2017-2028)

10.2.2 Middle East and Africa Polio Vaccine Revenue by Application (2017-2028)

10.3 Middle East and Africa Polio Vaccine Market Size by Country

10.3.1 Middle East and Africa Polio Vaccine Sales by Country (2017-2028)

10.3.2 Middle East and Africa Polio Vaccine Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Sanofi

11.1.1 Sanofi Corporation Information

11.1.2 Sanofi Overview

11.1.3 Sanofi Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Sanofi Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Recent Developments

11.2 GSK

11.2.1 GSK Corporation Information

11.2.2 GSK Overview

11.2.3 GSK Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 GSK Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 Bibcol

11.3.1 Bibcol Corporation Information

11.3.2 Bibcol Overview

11.3.3 Bibcol Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Bibcol Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Bibcol Recent Developments

11.4 Serum Institute

11.4.1 Serum Institute Corporation Information

11.4.2 Serum Institute Overview

11.4.3 Serum Institute Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Serum Institute Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Serum Institute Recent Developments

11.5 Tiantan Biological

11.5.1 Tiantan Biological Corporation Information

11.5.2 Tiantan Biological Overview

11.5.3 Tiantan Biological Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Tiantan Biological Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Tiantan Biological Recent Developments

11.6 IMBCA

11.6.1 IMBCA Corporation Information

11.6.2 IMBCA Overview

11.6.3 IMBCA Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 IMBCA Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 IMBCA Recent Developments

11.7 Panacea Biotec Ltd

11.7.1 Panacea Biotec Ltd Corporation Information

11.7.2 Panacea Biotec Ltd Overview

11.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Panacea Biotec Ltd Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Panacea Biotec Ltd Recent Developments

11.8 Bio-Med

11.8.1 Bio-Med Corporation Information

11.8.2 Bio-Med Overview

11.8.3 Bio-Med Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Bio-Med Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Bio-Med Recent Developments

11.9 Halfkin Bio-Pharmaceuticals

11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information

11.9.2 Halfkin Bio-Pharmaceuticals Overview

11.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Polio Vaccine Industry Chain Analysis

12.2 Polio Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Polio Vaccine Production Mode & Process

12.4 Polio Vaccine Sales and Marketing

12.4.1 Polio Vaccine Sales Channels

12.4.2 Polio Vaccine Distributors

12.5 Polio Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Polio Vaccine Industry Trends

13.2 Polio Vaccine Market Drivers

13.3 Polio Vaccine Market Challenges

13.4 Polio Vaccine Market Restraints

14 Key Findings in The Global Polio Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

Company

Japan

Russia

World Health Organization

List of Tables

Table 1. Global Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)

Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)

Table 4. Global Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 5. Global Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Polio Vaccine Sales by Region (2017-2022) & (M Doses)

Table 7. Global Polio Vaccine Sales Market Share by Region (2017-2022)

Table 8. Global Polio Vaccine Sales by Region (2023-2028) & (M Doses)

Table 9. Global Polio Vaccine Sales Market Share by Region (2023-2028)

Table 10. Global Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 11. Global Polio Vaccine Revenue Market Share by Region (2017-2022)

Table 12. Global Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 13. Global Polio Vaccine Revenue Market Share by Region (2023-2028)

Table 14. Global Polio Vaccine Sales by Manufacturers (2017-2022) & (M Doses)

Table 15. Global Polio Vaccine Sales Share by Manufacturers (2017-2022)

Table 16. Global Polio Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 17. Global Polio Vaccine Revenue Share by Manufacturers (2017-2022)

Table 18. Polio Vaccine Price by Manufacturers (2017-2022) &(USD/K Doses)

Table 19. Global Polio Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 20. Global Polio Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccine as of 2021)

Table 21. Polio Vaccine Manufacturing Base Distribution and Headquarters

Table 22. Manufacturers Polio Vaccine Product Offered

Table 23. Date of Manufacturers Enter into Polio Vaccine Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 26. Global Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 27. Global Polio Vaccine Sales Share by Type (2017-2022)

Table 28. Global Polio Vaccine Sales Share by Type (2023-2028)

Table 29. Global Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 30. Global Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 31. Global Polio Vaccine Revenue Share by Type (2017-2022)

Table 32. Global Polio Vaccine Revenue Share by Type (2023-2028)

Table 33. Polio Vaccine Price by Type (2017-2022) & (USD/K Doses)

Table 34. Global Polio Vaccine Price Forecast by Type (2023-2028) & (USD/K Doses)

Table 35. Global Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 36. Global Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 37. Global Polio Vaccine Sales Share by Application (2017-2022)

Table 38. Global Polio Vaccine Sales Share by Application (2023-2028)

Table 39. Global Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 40. Global Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 41. Global Polio Vaccine Revenue Share by Application (2017-2022)

Table 42. Global Polio Vaccine Revenue Share by Application (2023-2028)

Table 43. Polio Vaccine Price by Application (2017-2022) & (USD/K Doses)

Table 44. Global Polio Vaccine Price Forecast by Application (2023-2028) & (USD/K Doses)

Table 45. North America Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. North America Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 47. North America Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 48. North America Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 49. North America Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 50. North America Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 51. North America Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 52. North America Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 53. North America Polio Vaccine Sales by Country (2017-2022) & (M Doses)

Table 54. North America Polio Vaccine Sales by Country (2023-2028) & (M Doses)

Table 55. North America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 56. North America Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 57. Europe Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 58. Europe Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 59. Europe Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 60. Europe Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 61. Europe Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 62. Europe Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 63. Europe Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 64. Europe Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 65. Europe Polio Vaccine Sales by Country (2017-2022) & (M Doses)

Table 66. Europe Polio Vaccine Sales by Country (2023-2028) & (M Doses)

Table 67. Europe Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 68. Europe Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 69. Asia Pacific Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 70. Asia Pacific Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 71. Asia Pacific Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 72. Asia Pacific Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 73. Asia Pacific Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 74. Asia Pacific Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 75. Asia Pacific Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 76. Asia Pacific Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 77. Asia Pacific Polio Vaccine Sales by Region (2017-2022) & (M Doses)

Table 78. Asia Pacific Polio Vaccine Sales by Region (2023-2028) & (M Doses)

Table 79. Asia Pacific Polio Vaccine Revenue by Region (2017-2022) & (US$ Million)

Table 80. Asia Pacific Polio Vaccine Revenue by Region (2023-2028) & (US$ Million)

Table 81. Latin America Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 82. Latin America Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 83. Latin America Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 84. Latin America Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 85. Latin America Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 86. Latin America Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 87. Latin America Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 88. Latin America Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 89. Latin America Polio Vaccine Sales by Country (2017-2022) & (M Doses)

Table 90. Latin America Polio Vaccine Sales by Country (2023-2028) & (M Doses)

Table 91. Latin America Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 92. Latin America Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 93. Middle East and Africa Polio Vaccine Sales by Type (2017-2022) & (M Doses)

Table 94. Middle East and Africa Polio Vaccine Sales by Type (2023-2028) & (M Doses)

Table 95. Middle East and Africa Polio Vaccine Revenue by Type (2017-2022) & (US$ Million)

Table 96. Middle East and Africa Polio Vaccine Revenue by Type (2023-2028) & (US$ Million)

Table 97. Middle East and Africa Polio Vaccine Sales by Application (2017-2022) & (M Doses)

Table 98. Middle East and Africa Polio Vaccine Sales by Application (2023-2028) & (M Doses)

Table 99. Middle East and Africa Polio Vaccine Revenue by Application (2017-2022) & (US$ Million)

Table 100. Middle East and Africa Polio Vaccine Revenue by Application (2023-2028) & (US$ Million)

Table 101. Middle East and Africa Polio Vaccine Sales by Country (2017-2022) & (M Doses)

Table 102. Middle East and Africa Polio Vaccine Sales by Country (2023-2028) & (M Doses)

Table 103. Middle East and Africa Polio Vaccine Revenue by Country (2017-2022) & (US$ Million)

Table 104. Middle East and Africa Polio Vaccine Revenue by Country (2023-2028) & (US$ Million)

Table 105. Sanofi Corporation Information

Table 106. Sanofi Description and Major Businesses

Table 107. Sanofi Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 108. Sanofi Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 109. Sanofi Recent Developments

Table 110. GSK Corporation Information

Table 111. GSK Description and Major Businesses

Table 112. GSK Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 113. GSK Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. GSK Recent Developments

Table 115. Bibcol Corporation Information

Table 116. Bibcol Description and Major Businesses

Table 117. Bibcol Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 118. Bibcol Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Bibcol Recent Developments

Table 120. Serum Institute Corporation Information

Table 121. Serum Institute Description and Major Businesses

Table 122. Serum Institute Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 123. Serum Institute Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Serum Institute Recent Developments

Table 125. Tiantan Biological Corporation Information

Table 126. Tiantan Biological Description and Major Businesses

Table 127. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 128. Tiantan Biological Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Tiantan Biological Recent Developments

Table 130. IMBCA Corporation Information

Table 131. IMBCA Description and Major Businesses

Table 132. IMBCA Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 133. IMBCA Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. IMBCA Recent Developments

Table 135. Panacea Biotec Ltd Corporation Information

Table 136. Panacea Biotec Ltd Description and Major Businesses

Table 137. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 138. Panacea Biotec Ltd Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Panacea Biotec Ltd Recent Developments

Table 140. Bio-Med Corporation Information

Table 141. Bio-Med Description and Major Businesses

Table 142. Bio-Med Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 143. Bio-Med Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Bio-Med Recent Developments

Table 145. Halfkin Bio-Pharmaceuticals Corporation Information

Table 146. Halfkin Bio-Pharmaceuticals Description and Major Businesses

Table 147. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2017-2022)

Table 148. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Halfkin Bio-Pharmaceuticals Recent Developments

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Polio Vaccine Distributors List

Table 153. Polio Vaccine Customers List

Table 154. Polio Vaccine Market Trends

Table 155. Polio Vaccine Market Drivers

Table 156. Polio Vaccine Market Challenges

Table 157. Polio Vaccine Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Polio Vaccine Product Picture

Figure 3. Global Polio Vaccine Market Share by Type in 2021 & 2028

Figure 3. Inactivated Polio Vaccine (IPV) Product Picture

Figure 4. Oral Polio Vaccine (OPV) Product Picture

Figure 5. Global Polio Vaccine Market Share by Application in 2021 & 2028

Figure 6. Public

Figure 7. Private

Figure 8. Polio Vaccine Report Years Considered

Figure 9. Global Polio Vaccine Sales 2017-2028 (M Doses)

Figure 10. Global Polio Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 11. Global Polio Vaccine Revenue 2017-2028 (US$ Million)

Figure 12. Global Polio Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 13. Global Polio Vaccine Sales Market Share by Region (2017-2022)

Figure 14. Global Polio Vaccine Sales Market Share by Region (2023-2028)

Figure 15. North America Polio Vaccine Sales YoY (2017-2028) & (M Doses)

Figure 16. North America Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 17. Europe Polio Vaccine Sales YoY (2017-2028) & (M Doses)

Figure 18. Europe Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 19. Asia-Pacific Polio Vaccine Sales YoY (2017-2028) & (M Doses)

Figure 20. Asia-Pacific Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 21. Latin America Polio Vaccine Sales YoY (2017-2028) & (M Doses)

Figure 22. Latin America Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 23. Middle East & Africa Polio Vaccine Sales YoY (2017-2028) & (M Doses)

Figure 24. Middle East & Africa Polio Vaccine Revenue YoY (2017-2028) & (US$ Million)

Figure 25. The Polio Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 26. The Top 5 and 10 Largest Manufacturers of Polio Vaccine in the World: Market Share by Polio Vaccine Revenue in 2021

Figure 27. Global Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 28. Global Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 29. Global Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 30. Global Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 31. Global Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 32. North America Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 33. North America Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 34. North America Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 35. North America Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 36. North America Polio Vaccine Sales Share by Country (2017-2028)

Figure 37. North America Polio Vaccine Revenue Share by Country (2017-2028)

Figure 38. U.S. Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 39. Canada Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 40. Europe Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 41. Europe Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 42. Europe Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 43. Europe Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 44. Europe Polio Vaccine Sales Share by Country (2017-2028)

Figure 45. Europe Polio Vaccine Revenue Share by Country (2017-2028)

Figure 46. Germany Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 47. France Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 48. U.K. Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 49. Italy Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 50. Russia Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 51. Asia Pacific Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 52. Asia Pacific Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 53. Asia Pacific Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 54. Asia Pacific Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 55. Asia Pacific Polio Vaccine Sales Share by Region (2017-2028)

Figure 56. Asia Pacific Polio Vaccine Revenue Share by Region (2017-2028)

Figure 57. China Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 58. Japan Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 59. South Korea Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 60. India Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 61. Australia Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 62. Taiwan Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 63. Indonesia Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 64. Thailand Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 65. Malaysia Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 66. Philippines Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 67. Latin America Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 68. Latin America Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 69. Latin America Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 70. Latin America Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 71. Latin America Polio Vaccine Sales Share by Country (2017-2028)

Figure 72. Latin America Polio Vaccine Revenue Share by Country (2017-2028)

Figure 73. Mexico Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 74. Brazil Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 75. Argentina Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 76. Middle East and Africa Polio Vaccine Sales Market Share by Type (2017-2028)

Figure 77. Middle East and Africa Polio Vaccine Revenue Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Polio Vaccine Sales Market Share by Application (2017-2028)

Figure 79. Middle East and Africa Polio Vaccine Revenue Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Polio Vaccine Sales Share by Country (2017-2028)

Figure 81. Middle East and Africa Polio Vaccine Revenue Share by Country (2017-2028)

Figure 82. Turkey Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 83. Saudi Arabia Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 84. U.A.E Polio Vaccine Revenue (2017-2028) & (US$ Million)

Figure 85. Polio Vaccine Value Chain

Figure 86. Polio Vaccine Production Process

Figure 87. Channels of Distribution

Figure 88. Distributors Profiles

Figure 89. Bottom-up and Top-down Approaches for This Report

Figure 90. Data Triangulation

Figure 91. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Polio Vaccine Market Insights and Forecast to 2028

Published Date: January 2022

Report Code: QYRE-Auto-34U455

Global Polio Vaccine Market Insights and Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26K6048

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-20L6129

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-4F6384

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-16N6009

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions